Ultrasonic probes were placed around dog femoral arteries to record blood flow. Hind paw scalding with boiling water (5 s) caused a marked increase in ipsilateral femoral blood flow that persisted for the 2-h observation period. Contralateral femoral blood flow and systemic and pulmonary vascular resistances were unchanged. Compared to scald only animals, methysergide pretreatment diminished and shortened the femoral vasodilator response to scald (109±14 vs 243±27 ml/min at 5 min; 59±14 vs 191±31 ml/min at 2 h). Pretreatment with ritanserin, BW A1433U83, atropine, ICI 118551, diphenhydramine, ranitidine, meclofenamate, L-nitro-arginine methyl ester, 3-amino-1,2,4-triazine, and U 37883A had no effect on the increased femoral blood flow response to scald, suggesting this vasodilator response is not dependent upon activation of serotonergic2, adenosineAl, muscarinic, l2-adrenergic, histaminergic1 or histaminergic2 receptors, on cyclooxygenase products, endothelium-derived relaxing factor derived from nitric oxide (NO) synthase III, NO derived from NO synthase II, or KATp channels, respectively. Methysergide given after burn immediately reduced the augmented femoral blood flow to preburn levels, suggesting the vasodilator response to scald is mediated through continual activation of local serotonergicl-like receptors, which may be target site(s) for therapeutic interventions to influence burn-induced hemodynamic alterations. (J. Clin.
Introduction
In patients with large body surface area (BSA)' burns, both cardiac output and blood flow to the injured area are increased for several days (1, 2) . Animal studies have also documented a 1. Abbreviations used in this paper: 3-ATINE, 3-amino-l1,2,4-triazine; BSA, body surface area; CATM, 5-carboxamidotryptamine; CI, cardiac index; CNS, central nervous system; CO, cardiac output; EDRF, endothelium-derived relaxing factor; L-NAME, L-nitro-arginine methyl ester; MAP, mean arterial pressure; MET, methysergide; NOS, nitric oxide synthase; PAP, pulmonary artery pressure; PCWP, pulmonary capillary wedge pressure; RIT, ritanserin. prolonged increase in blood flow to a large wound (3) . However, acute alterations in blood flow to a burn site are poorly delineated. In guinea pigs, a large BSA burn produces an acute decrease in blood flow to the wound, likely caused by diminished cardiac output (4) . A smaller BSA burn in rats causes only an increase in blood flow to the injured site, a response influenced by surface temperature and injury size (5) . Mediation ofthis regional vasodilator response by potassium, prostaglandins, lactate, and activation of f3-adrenoceptors (3, (6) (7) (8) (9) has been suggested. Others consider heat-induced vasodilation a prime component of this response (5) . The role of these vasodilatory mechanisms is unclear.
These experiments were designed to characterize the effect of a small BSA scald on systemic, pulmonary, and regional (burned and unburned sites) hemodynamics. The effects of blocking agents for known vasoactive receptors and potassium channels on burn-induced hemodynamic alterations were also investigated. These data indicate that in the absence of systemic or pulmonary hemodynamic effects, blood flow to the injured area acutely increased, and regional vascular resistance decreased. These responses were selectively inhibited by the serotonin receptor blocking agent, methysergide. Since ritanserin, a serotonin2 receptor blocking agent, had no effect on these alterations, the data suggest that continuous activation of serotonin1-like receptors mediates, in large measure, these responses.
Methods
Surgicalprotocol. Adult mongrel dogs weighing 20-35 kg were anesthetized with intravenous sodium pentobarbital (25 mg/kg per h) and placed on room air mechanical ventilation. Systemic mean arterial pressure (MAP, mmHg) was measured through a cannulated brachial artery. Pulmonary artery pressure (PAP, mmHg) and pulmonary capillary wedge pressure (PCWP, mmHg) were monitored by insertion ofa balloon-tipped pulmonary artery catheter via internal jugular vein cutdown. Ringer's lactate solution (2-3 ml/ kg per h) was infused to maintain baseline MAP Figure 1 . Effects of hind paw scald on regional and systemic hemodynamics. The threefold increase in femoral blood flow (A) and decrease in femoral vascular resistance (D) to the site of injury occurs without blood flow alterations to unburned tissues, systemic mean arterial pressure (B), or systemic vascular resistance (C).
for 2 h with no further intervention. Remaining animals were exposed to scald injury, immersion of one hind paw (< 3% BSA) into 100°C water for 5 s, and hemodynamic parameters were monitored for 2 h thereafter. Since in scald only animals (controls, n = 9), identical increases in hind limb blood flow and decreases in hind limb vascular resistance occurred regardless of which paw (right [n = 5] or left [n = 4]) was injured, they were combined into one group. In subsequent 2 - groups of dogs, one of the following agents was intravenously infused 20 min before scalding, in a dose shown to adequately block the respective agonist agent response: methysergide (0.1 mg/kg, n = 7), ritanserin (0.1 mg/kg, n = 5), atropine (1 mg/kg, n = 4), ICI 118551 (1 mg/kg, n = 4), BW A1433U83 (7.5 mg/kg, n = 6), sodium meclofenamate (2.5 mg/kg, n = 4), diphenhydramine ( 1 mg/kg, n = 5), ranitidine (1 mg/kg, n = 4); L-nitro-arginine methyl ester (L-NAME, 100 mg/kg, n = 7), 3-amino-1,2,4-triazine (3-ATINE, 75 mg/kg, n = 3), or U 37883A (2.5 mg/kg, n = 4).
To further elucidate what was found to be a methysergide-sensitive femoral vasoactive response in animals pretreated with that agent, additional protocols were carried out. In separate groups of animals, methysergide was given no sooner than 30 min after scald: (a) by peripheral intravenous injection (0.1 mg/kg, n = 4; 1.0 mg/kg, n = 3) and (b) by bolus injection directly into the femoral artery on the side of injury (20 gg/kg, n = 4). In another group (n = 4) of dogs, methysergide (20 ,g/kg) was infused into the cranial circulation via one common carotid artery before scalding. Finally, to determine the specificity of the femoral vasoactive response to methysergide, random sequence intrafemoral artery injections of the following vasoconstrictor and vasodilator agents were performed in a group (n = 5) of unburned dogs before and after peripheral intravenous administration ofmethysergide Statistical analysis. Data are presented as means (±1 SE). Comparisons both within a given group and between groups were made using ANOVA. Whenever a significant F ratio was reached, Fisher's PSLD test was applied to detect specific differences. Significance was accepted when P < 0.05.
Results
Immediately after the scalding, there was a significant threefold increase in femoral artery blood flow to the injured hind limb (Fig. I A) , reaching peak levels within 5 min. Over the next 25 min, a slight decline in blood flow to a plateau phase was observed, though it remained significantly elevated throughout the 2-h observation period. Since neither systemic MAP (Fig. 1  B) nor systemic vascular resistance (Fig. 1 C) were significantly altered by the scald, the increase in femoral blood flow ipsilateral to the injury reflected a decrease in hind limb vascular resistance (Fig. 1 D) . Finally, CI increased slightly but insignificantly upon scald injury (Fig. 2) . Mean PAP, PCWP, and pulmonary vascular resistance were unaltered by scalding (Table I) .
In some animals (data not shown), an additional ultrasonic flow probe was placed around the ipsilateral dorsalis pedis ar- tery, immediately proximal to the proposed site of scald. Baseline dorsalis pedis blood flows were approximately one fourth those of femoral blood flows. After scalding, dorsalis pedis blood flows increased dramatically when compared to baseline levels, and remained elevated throughout the observation period. In contrast to the injured side, the unburned hind limb showed no significant changes in blood flow or in vascular resistance.
Femoral artery blood flow, systemic MAP, and CI were monitored before scald in dogs pretreated with methysergide. This dose of methysergide was found to block the increased regional blood flow induced by intrafemoral arterial bolus injections ofserotonin ( 10-100 ,ig/kg), which itselfproduced no systemic hemodynamic effects. After femoral artery blood flow returned to baseline, methysergide (0.1 mg/kg) was administered by the peripheral intravenous route; no significant regional or systemic hemodynamic alterations occurred (Table  II) . However, the subsequent intrafemoral bolus injection of serotonin resulted in significant (P < 0.002) blunting of the hyperemic response to serotonin before methysergide (65±10 ml/min increase in blood flow before methysergide; 10±3 ml/ min blood flow increase after methysergide).
In these same methysergide-treated dogs, scalding still caused an immediate, significant increase in femoral blood flow (Fig. 3 A) and a decrease in regional vascular resistance (Fig. 3 B) . However, when compared to burn alone dogs, the regional hemodynamic alterations were significantly blunted. Moreover, within 30 min, femoral blood flow and vascular resistance had begun to return toward preinjury levels, reaching baseline levels by 60 min. At all observation points, the values for each represent significant differences from burn only dogs.
To determine whether this agent could reverse the vasodilator response to scald, dogs were given methysergide intravenously (0.1 mg/kg) 30 min after injury. Immediately thereafter, femoral blood flow decreased (Fig. 4 A) and vascular resistance increased (Fig. 4 B) , each reaching preburn levels within 30 min. Tenfold higher doses of methysergide had similar effects (data not shown).
To determine the selectivity ofmethysergide to inhibit femoral vasodilator responses mediated by serotonergic receptors, an additional group of experiments was performed, and data from these studies are presented in Table III ninlA-like receptor agonist, 0.0001 ,ug/kg), nitroglycerin (a direct activator of guanylate cyclase, 0.003 ,ug/kg), and verapamil (a calcium channel blocking agent, 0.001 ,ug/kg) all significantly increased femoral blood flow while methoxamine (0.1 ,ug/kg) significantly reduced femoral blood flow. Since none of these agents altered systemic mean arterial pressure, the increases in femoral blood flow produced by these agents directly reflect decreases in hind limb vascular resistance. 5 min after peripheral intravenous administration of methysergide (0.1 mg/kg), the hind limb vasodilator responses to serotonin and CATM were significantly decreased, whereas the hind limb vasodilator responses to nitroglycerin and verapamil were not significantly altered, nor was the hind limb vasoconstrictor response to methoxamine. These data suggest that methysergide selectively inhibited the hind limb vasodilator responses mediated by serotonergic, receptors.
As methysergide readily crosses the blood brain barrier (10) , serotoninergic receptors within the central nervous system (CNS) could have mediated the scald-induced alterations in regional hemodynamics. Therefore, the contribution of CNS receptors to this response was investigated in dogs given methysergide (20 ,ug/kg) into one common carotid artery before scalding. This dose was found to be the largest intracarotid In the absence of alterations in systemic mean arterial pressure, methysergide selectively blocked the vasodilator response to serotonin and CATM, but had no effect on the vasodilator response to nitroglycerin or verapamil, or on the vasoconstrictor response to methoxamine. * P < 0.01 vs pre-MET.
dose that did not alter the hind limb vasodilator response to femoral artery injection of serotonin ( 10-100 l g/kg). Before scald, bolus intracarotid injection of methysergide did not significantly alter baseline systemic or regional hemodynamic measurements. In these same dogs, the characteristic femoral blood flow and vascular resistance responses to scald were not altered by the centrally administered methysergide (Table IV) . In contrast, the same dose of methysergide given preburn into the femoral artery of other dogs inhibited the femoral vasodilator response to scald (Fig. 5) .
To further characterize the serotoninergic receptor subtype mediating these regional vasodilator responses, ritanserin (0.1 mg/kg), a serotonin2 receptor antagonist ( 11 ) , was given intravenously to dogs before scald. This dose blocked the intrafemoral administration ofthe serotonin2 receptor agonist ( + )-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride (10 ,tg/kg) after intravenous ritanserin produced no effects on femoral blood flow or femoral vascular resistance. Preburn ritanserin injection had no effect on systemic or regional hemodynamic measurements at any observation point (Table II) . The contribution of other vasodilator mechanisms was investigated by administering one of the following blocking agents to groups of animals before scalding: atropine (muscarinic receptors), ICI 118551 ( 32-adrenoceptors), BW A 1 433U83 (adenosineAl receptors), meclofenamate (cyclooxygenase enzyme system), diphenhydramine (histaminergic, receptors), and ranitidine (histaminergic2 receptors). These agents were given in doses that blocked the femoral vasodilator responses to intrafemoral bolus injections ofacetylcholine, isoproterenol, adenosine, arachidonic acid, and histamine, respectively (Table V) . The antagonists did not alter baseline systemic MAP, CI, or hind limb blood flow, nor did they alter the hemodynamic response to scald (Table VI) .
The contribution of endothelium-derived relaxing factor (EDRF) to this vasodilator response was assessed by giving L-NAME (100 mg/kg), an inhibitor of nitric oxide synthase III ( 12 ). In unburned animals, administration ofL-NAME before ( 13) . 3-ATINE had no effect on baseline systemic or regional hemodynamics or on regional blood flow after scald injury.
The contribution of KATP channels in mediating the regional vasodilatory response to scald was assessed with U 37883A, a selective inhibitor of KATP channels ( 14). In doses that selectively blocked the hind limb vasodilator response to cromakalim, an activator of KATP channels, this dose did not affect the vasodilator response to isoproterenol or nitroglycerin (data not shown). Given before the burn, U 37883A had no effect on the hind limb vasodilator response to scald (Table VII) .
Discussion
Data from this study demonstrate that in the absence of systemic or pulmonary hemodynamic changes, a small BSA burn in dogs results in a marked increase in blood flow to the site of injury concomitant with a decrease in vascular resistance. These results are consistent with studies that suggest the vasodilator response to a surface wound is primarily directed to that wound, not to uninjured tissues or adjacent "watershed" areas (1, 2, 15) . This study was designed to limit the size and magnitude of the burn to the extent that there were no appreciable alterations in (a) systemic and pulmonary hemodynamic parameters and (b) blood flow and vascular resistance to skin/soft tissue remote from the burn site. Each of these goals was met throughout the experiments reported herein by standardizing the scald: (a) the percent BSA injury was uniformly < 3% and (b) a second degree burn was consistently produced, characterized by cutaneous hyperemia, skin blisters, and subcutaneous tissue swelling. Thus, in large measure, the direct impact of scald on regional hemodynamics was monitored. As such, data from this study are consistent with others that show a small BSA Regional Hemodynamic Regulation after Burn 151 The burn alone group is shown for comparative purposes. In each group, the injected blocking agent had no effect on the scald-induced regional vasodilatory response. P = NS vs control burn group at each time interval.
scald increases blood flow for tissues involved in the burn, but does not alter pulmonary, systemic, or regional hemodynamics (5). The marked hind limb vasodilator response to scald injury was significantly reduced by administering methysergide but not ritanserin before the burn, suggesting that serotonin1-like receptors play a major role in mediating this response. Since methysergide inhibited the hind limb vasodilator response to serotonin and CATM, but not to nitroglycerin or verapamil, the present data suggest that methysergide acted in a selective manner to antagonize serotonergic,-like receptors. Although prostaglandins (7, 8) and 2-adrenoceptors (9) have been implicated as mediators ofthe increase in local blood flow, neither ICI 1 1855 1 nor meclofenamate altered the hind limb vasodilator response to burn, suggesting that neither #2-adrenoceptors nor cyclooxygenase products appear to mediate this effect. Similarly, atropine, BW 1433U83, diphenhydramine, and ranitidine had no effect on the scald-induced increase in femoral blood flow, suggesting that this response is not mediated by muscarinic, adenosineAl, histaminergic,, or histaminergic2-receptors.
The vasorelaxant response to serotonin in isolated conduit blood vessels has been shown to require an intact endothelial cell layer and to depend on formation of EDRF (16) . Since pretreatment with L-NAME and 3-ATINE, respective inhibitors of NOS III-forming EDRF (12, 13, (16) (17) (18) (19) and NOS II (20) , did not alter the vasodilator response to scald, these data suggest that NO formed from the constitutive and inducible forms of NO synthase does not mediate this effect to a large degree. 
112±9
Of the blocking agents tested, none altered scald-induced regional vasodilatory response to injury. * P < 0.02 vs baseline. * P < 0.02 vs pre-burn.
Recently, KATP channels have been identified in skeletal muscle and arterial smooth muscle ( 14). The possibility that this vasodilator response may be mediated by activation of these channels is unlikely, since U 37883A, an inhibitor of KATP channels, had no effect on the hind limb vasodilator response to burn injury. Since methysergide crosses the blood brain barrier ( I I ), the hypothesis that serotonin receptors within the CNS mediate the femoral vasodilator response to scald was tested. Intracarotid arterial injection ofmethysergide did not alter the hind limb vasodilator response to scald or to femoral artery injection of serotonin. In contrast, the same methysergide dose given directly into the femoral vascular bed inhibited the hind limb vasodilator response to scald and to femoral artery injection of serotonin. These data suggest that serotonin1-like receptors activated locally, not centrally, mediate the hind limb vasodilator response to scald.
Since pretreatment with methysergide prevented the hind limb vasodilator response to scald, serotoninergic receptors contribute in large measure to this effect. Moreover, this response to scald was rapidly reversed by administration ofmethysergide after the burn. These data suggest that persistent activation of serotonin,-like receptors mediates the prolonged increase in hind limb blood flow after scald. Although mediation of this response may be species dependent, the present study is unique by providing evidence that a specific vasodilator mechanism, serotonin,-like receptors, is directly responsible for the sustained vasodilator response to local thermal injury. Since methysergide given either into the femoral artery (20 
